SCHEMBL6270171

SCHEMBL6270171

NC(=O)CC1CCCC1.O=C(O)CC1CCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.44
ENPEP Q07075 1/20 0.44
SLC6A12 P48065 4/20 0.42
SLC6A11 P48066 4/20 0.42
SLC6A13 Q9NSD5 4/20 0.42
ALOX5 P09917 3/20 0.42
SLC6A1 P30531 2/20 0.42
GABRA5 P31644 2/20 0.42
GABRB2 P47870 2/20 0.42
GABRA1 P14867 1/20 0.42
GABRR1 P24046 1/20 0.42
GABRA4 P48169 1/20 0.42
EPHX1 P07099 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
SLC1A3 P43003 3/20 0.39
SLC1A2 P43004 3/20 0.39
SLC1A1 P43005 3/20 0.39
EPHX2 P34913 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL302210 0.91
SCHEMBL29291470 0.88 EPHX1 (0.50) ALOX5EPHX1HPGDKMT2ASLC1A3
Hydrochloric Acid SCHEMBL27767977 0.88 ALOX5 (0.46) ALOX5EPHX1HPGDKMT2ASLC1A3
SCHEMBL1327157 0.88 EPHX1 (0.50) ALOX5EPHX1HPGDKMT2ASLC1A3
SCHEMBL20379771 0.88 EPHX1 (0.50) ALOX5EPHX1HPGDKMT2ASLC1A3
SCHEMBL29291474 0.88 EPHX1 (0.50) ALOX5EPHX1HPGDKMT2ASLC1A3
SCHEMBL24986 0.88 EPHX1 (0.50) ALOX5EPHX1HPGDKMT2ASLC1A3
SCHEMBL221946 0.88
SCHEMBL8915603 0.86 EPHX1 (0.48) ALOX5EPHX1HPGDKMT2ASLC1A3
Hydrochloric Acid SCHEMBL6921995 0.86 EPHX1 (0.48) ALOX5EPHX1HPGDKMT2ASLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1606244-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT Abbott Laboratories (US) 2005-12-21 EP disclosed
WO-2004037769-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT ABBOTT LABORATORIES (US) 2004-05-06 WO disclosed